Literature DB >> 6347058

Automated fluorescence polarization immunoassay for monitoring streptomycin.

K S Schwenzer, J P Anhalt.   

Abstract

The fluorescence polarization immunoassay technique has been used previously for the assay of vancomycin and the aminoglycoside antibiotics (gentamicin, tobramycin, and amikacin). We extended this technique to assay streptomycin. Fluorescein-labeled streptomycin was used as the tracer, and antiserum specific for streptomycin was raised in rabbits by conventional procedures. Tracer, sample, and diluted antiserum were combined, and the polarization of tracer fluorescence was determined in a specially designed fluorometer (Abbott TDx). Because of the instrument design, the possibility of fluorescent interferences was eliminated. The coefficient of variation within run was 4% (n = 5), and between run it was 5% (n = 5). We compared the fluorescence polarization immunoassay technique (TDx streptomycin) with a conventional bioassay, using Bacillus subtilis for clinical specimens (n = 39). A least-squares linear regression analysis gave a slope of 1.16, an intercept of 2.41 mg/liter, and a correlation coefficient of 0.885. Repeat analyses by both techniques showed that the largest discrepancies could be explained by the imprecision of the bioassay.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347058      PMCID: PMC184787          DOI: 10.1128/AAC.23.5.683

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Fluorescence polarization immunoassay. II. Analyzer for rapid, precise measurement of fluorescence polarization with use of disposable cuvettes.

Authors:  S R Popelka; D M Miller; J T Holen; D M Kelso
Journal:  Clin Chem       Date:  1981-07       Impact factor: 8.327

2.  Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma.

Authors:  M E Jolley; S D Stroupe; C H Wang; H N Panas; C L Keegan; R L Schmidt; K S Schwenzer
Journal:  Clin Chem       Date:  1981-07       Impact factor: 8.327

3.  Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma.

Authors:  M E Jolley
Journal:  J Anal Toxicol       Date:  1981 Sep-Oct       Impact factor: 3.367

4.  Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination.

Authors:  M E Jolley; S D Stroupe; K S Schwenzer; C J Wang; M Lu-Steffes; H D Hill; S R Popelka; J T Holen; D M Kelso
Journal:  Clin Chem       Date:  1981-09       Impact factor: 8.327

5.  Individualizing gentamicin dosage regimens in burn patients with gram-negative septicemia: a cost--benefit analysis.

Authors:  J L Bootman; A I Wertheimer; D Zaske; C Rowland
Journal:  J Pharm Sci       Date:  1979-03       Impact factor: 3.534

6.  Drug therapy reviews: Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics--part 4: aminoglycosides.

Authors:  M Barza; R T Scheife
Journal:  Am J Hosp Pharm       Date:  1977-07

7.  Immunofluorescence using dichlorotriazinylaminofluorescein (DTAF). II. Preparation, purity and stability of the compound.

Authors:  D Blakeslee
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

8.  Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis.

Authors:  P Noone; T M Parsons; J R Pattison; R C Slack; D Garfield-Davies; K Hughes
Journal:  Br Med J       Date:  1974-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.